1. Home
  2. RLMD vs TOYO Comparison

RLMD vs TOYO Comparison

Compare RLMD & TOYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • TOYO
  • Stock Information
  • Founded
  • RLMD 2004
  • TOYO 2022
  • Country
  • RLMD United States
  • TOYO Japan
  • Employees
  • RLMD N/A
  • TOYO N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • TOYO
  • Sector
  • RLMD Health Care
  • TOYO
  • Exchange
  • RLMD Nasdaq
  • TOYO NYSE
  • Market Cap
  • RLMD 110.6M
  • TOYO 115.2M
  • IPO Year
  • RLMD N/A
  • TOYO N/A
  • Fundamental
  • Price
  • RLMD $2.75
  • TOYO $2.76
  • Analyst Decision
  • RLMD Hold
  • TOYO
  • Analyst Count
  • RLMD 2
  • TOYO 0
  • Target Price
  • RLMD $7.50
  • TOYO N/A
  • AVG Volume (30 Days)
  • RLMD 126.6K
  • TOYO 22.9K
  • Earning Date
  • RLMD 11-07-2024
  • TOYO 08-21-2024
  • Dividend Yield
  • RLMD N/A
  • TOYO N/A
  • EPS Growth
  • RLMD N/A
  • TOYO N/A
  • EPS
  • RLMD N/A
  • TOYO 0.76
  • Revenue
  • RLMD N/A
  • TOYO $200,455,385.00
  • Revenue This Year
  • RLMD N/A
  • TOYO N/A
  • Revenue Next Year
  • RLMD N/A
  • TOYO N/A
  • P/E Ratio
  • RLMD N/A
  • TOYO $3.86
  • Revenue Growth
  • RLMD N/A
  • TOYO N/A
  • 52 Week Low
  • RLMD $1.88
  • TOYO $1.36
  • 52 Week High
  • RLMD $7.22
  • TOYO $15.61
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 23.58
  • TOYO N/A
  • Support Level
  • RLMD $2.96
  • TOYO N/A
  • Resistance Level
  • RLMD $3.43
  • TOYO N/A
  • Average True Range (ATR)
  • RLMD 0.21
  • TOYO 0.00
  • MACD
  • RLMD -0.07
  • TOYO 0.00
  • Stochastic Oscillator
  • RLMD 1.60
  • TOYO 0.00

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About TOYO TOYO CO LTD

Toyo Co Ltd along with its subsidiaries is engaged in research and development, production, and sales of solar cells.

Share on Social Networks: